Search the
company directory

Alexis Technologies AG 

Bern · Since 2019

The core activity of Alexis Technologies is the development of innovative solutions for in-vitro testing of respiratory diseases and the development of new inhalable therapies. To this end, the company combines three groundbreaking technologies: Advanced Bioengineering, Advanced Human Tissue Modelling, and Advanced in-vitro Inhalation.

AlveoliX AG 

Bern · Since 2024

AlveoliX AG develops organs-on-chip technologies and provides modular systems and biomodels for in vitro testing and preclinical research. Its portfolio includes the AX Barrier-on-Chip and AX Lung-on-Chip systems, the AX12 platform, and services for developing custom biomodels and running safety, efficacy and toxicity assays.

AlveoliX Technologies AG 

Bern · Since 2015

AlveoliX Technologies AG develops organs-on-chip platforms and supplies the AX Barrier‑on‑Chip System with its modular components. The company produces AX12-based biomodels using human-derived cells and offers research and service support for barrier and lung models for in vitro safety and efficacy testing.

Berner Stiftung für krebskranke Kinder und Jugendliche 

Bern · Since 1988

The core activity of the Bern Foundation for children and adolescents with cancer consists of promoting and supporting projects and activities that deal with the diagnosis, treatment and care of children and adolescents with cancer. This includes in particular the support of research projects, the improvement of the quality of life of children and adolescents with cancer, as well as the provision of resources and services for the affected families. The foundation works closely with the University Children's Hospital Bern and other partners to achieve its goals.

Bestattungsdienste ISB Bern AG 

Bern · Since 1998

Bestattungsdienste ISB Bern AG provides funeral services, including organisation of funerals, care and lay-out of the deceased, provision of coffins and urns, funeral stationery and floristry, and domestic and international transfers of the deceased.

Bosonic AG 

Bern · Since 2019

The core activity of BoSonic AG is the development and manufacture of medical devices, particularly surgical cutting instruments with ultrasound technology (Piezo-Surgery), which are used in precision surgery. The company focuses on improving the safety, usability and performance of these devices to enhance the quality of surgical interventions and improve patient outcomes.

DCB Research AG 

Bern · Since 2017

DCB Research AG supports the development of diabetes technologies by providing expertise, clinical research services, laboratory facilities and funding. Its services include clinical study management, regulatory and data services, business and communication support, and collaboration on research projects and publications.

Decomplix AG 

Bern · Since 2016

The Decomplix AG supports customers in the approval and market access of medical devices, particularly in the field of software for medical devices. The core activities include the creation of regulatory strategies, the implementation of risk classifications, compliance with quality management and compliance requirements, as well as support in CE certification. Decomplix offers its customers individually tailored services to simplify and accelerate market access for medical devices.

Diabetes Center Berne Foundation 

Bern · Since 2017

Diabetes Center Berne Foundation supports the development of diabetes technologies by providing expertise, access to clinical research facilities, laboratory services and funding. As a nonprofit foundation it promotes independent research and patient‑benefit projects and offers clinical, regulatory, data, business and communication services to help bring solutions closer to market entry.

Ikerian AG 

Bern · Since 2016

The core activity of RetinAI (Ikerian AG) is the development and provision of software solutions for medical image processing and analysis, particularly in the field of ophthalmology, with a focus on artificial intelligence (AI) and machine learning. The company's products, such as the DISCOVERY and UNITY platforms, support doctors and researchers in diagnosing and treating eye diseases, as well as conducting clinical trials.